Skip to search formSkip to main contentSkip to account menu

olanzapine 15 MG Disintegrating Oral Tablet

Known as: OLANZAPINE 15MG,TAB RAPID DISINTEGRATING [VA Product], OLANZAPINE 15 mg ORAL TABLET, ORALLY DISINTEGRATING [Olanzapine], Olanzapine 15 mg ORAL TABLET, ORALLY DISINTEGRATING 
National Institutes of Health

Related topics

Related topics

33 relations
Adrenergic alpha-Antagonists [MoA]Antipsychotic AgentsAspartameBenzyl Alcohol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia
2014
2014
Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
BACKGROUND The incidence of extrapyramidal symptoms (EPS) has been shown to be generally low among patients with schizophrenia… 
Review
2013
Review
2013
Author ' s response to reviews Title : Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection : post hoc analysis of a randomized…
Background: Hospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No… 
Review
2012
Review
2012
Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
Abstract Objective: To assess the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)